CHINA FEIHE (06186) spent 9.49 million Hong Kong dollars to repurchase 2.3 million shares on November 26th.

17:17 26/11/2025

China Feihe (06186) announced that the company spent HK$94.901 million on November 26, 2025...

CHINA FEIHE (06186) announced that the company will spend 9.4901 million Hong Kong dollars to repurchase 2.3 million shares on November 26, 2025, at a repurchase price of 4.12-4.14 Hong Kong dollars per share.

Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.